FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

23424811000001105: Alogliptin benzoate (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2014. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    76681401000001115 Alogliptin benzoate (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    76681501000001116 Alogliptin benzoate en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Alogliptin benzoate Is a Oral hypoglycemic false Inferred relationship Existential restriction modifier
    Alogliptin benzoate Is a Substance with dipeptidyl peptidase IV inhibitor mechanism of action false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Alogliptin 25mg tablets Has specific active ingredient False Alogliptin benzoate Inferred relationship Existential restriction modifier
    Alogliptin 25mg tablets 28 tablet Has specific active ingredient False Alogliptin benzoate Inferred relationship Existential restriction modifier
    Vipidia 25mg tablets (Takeda UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient False Alogliptin benzoate Inferred relationship Existential restriction modifier
    Vipidia 25mg tablets (Takeda UK Ltd) Has specific active ingredient False Alogliptin benzoate Inferred relationship Existential restriction modifier
    Vipidia 12.5mg tablets (Takeda UK Ltd) Has specific active ingredient False Alogliptin benzoate Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg tablets Has specific active ingredient False Alogliptin benzoate Inferred relationship Existential restriction modifier
    Vipidia 12.5mg tablets (Takeda UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient False Alogliptin benzoate Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg tablets 28 tablet Has specific active ingredient False Alogliptin benzoate Inferred relationship Existential restriction modifier
    Vipdomet 12.5mg/1000mg tablets (Takeda UK Ltd) Has specific active ingredient False Alogliptin benzoate Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets Has specific active ingredient False Alogliptin benzoate Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets 56 tablet Has specific active ingredient False Alogliptin benzoate Inferred relationship Existential restriction modifier
    Vipdomet 12.5mg/1000mg tablets (Takeda UK Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient False Alogliptin benzoate Inferred relationship Existential restriction modifier
    Alogliptin 6.25mg tablets Has specific active ingredient False Alogliptin benzoate Inferred relationship Existential restriction modifier
    Vipidia 6.25mg tablets (Takeda UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient False Alogliptin benzoate Inferred relationship Existential restriction modifier
    Vipidia 6.25mg tablets (Takeda UK Ltd) Has specific active ingredient False Alogliptin benzoate Inferred relationship Existential restriction modifier
    Alogliptin 6.25mg tablets 28 tablet Has specific active ingredient False Alogliptin benzoate Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start